Distinctive serum lipidomic profile of IVIG-resistant Kawasaki disease children before and after treatment

PLoS One. 2023 Mar 29;18(3):e0283710. doi: 10.1371/journal.pone.0283710. eCollection 2023.

Abstract

Kawasaki Disease (KD) is an acute inflammatory disorder associated with systemic vasculitis. Intravenous immunoglobulin (IVIG) is an effective therapy for KD, yet, about 20% of cases show IVIG resistance with persistent inflammation. The lipid profile in IVIG-resistant KD patients and the relationship between lipid characteristics and IVIG resistance remain unknown. In this study, serum samples from twenty KD patients with different IVIG responses (sensitive, intermediate, or resistant) were collected both before and after treatment, and lipidomic analysis was performed using high-performance liquid chromatography-mass spectrometry. As a result, before treatment, six lipid species were found as the most variant features, in which all the top decreased lipids in the IVIG-resistant group were lysophosphatidylcholine (LPC) and lysophosphatidylethanolamine (LPE), suggesting the potential to be IVIG-resistant markers in pretreatment diagnosis. During treatment, lipidomic changes showed a weaker response in the IVIG-resistant group. After treatment, LPC and LPE species exhibited lower in the IVIG-resistant group and negative correlation with the inflammatory markers, indicating that the unique metabolism may occur among IVIG-responsiveness. These results might contribute to diagnosing IVIG-resistant patients more accurately for alternative therapy and to a better understanding of how lipid metabolism is associated with IVIG sensitiveness/resistance in KD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Infant
  • Lipidomics
  • Lipids
  • Mucocutaneous Lymph Node Syndrome* / complications
  • Retrospective Studies

Substances

  • Immunoglobulins, Intravenous
  • Lipids

Grants and funding

This study was supported by (1) grants from the Japan Blood Products Organization and Japan Kawasaki Disease Research Center to Shuji Sai, and (2) Hokkaido University “Research Fund Program for Early Career Scientists” to Zhen Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.